Skip to main content
OpenTrials
Completed

NCT Number: NCT07205848

Evaluating Public Awareness and Preventive Actions for Dengue Fever in Sudan Amidst Ongoing Crises

This study evaluates the awareness of dengue fever and preventive measures among Sudanese people during the war. It assesses knowledge, awareness, implementation of prevention, access to healthcare, community involvement, and the link between knowledge and practice. The findings aim to enhance disease control strategies in conflict settings.

Completed

Looking for future studies?

Notify Me

Key information

Age range

17 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Research and publication office

Khartoum, Omdurman, 11111, Sudan

About this study

This study aims to evaluate the level of awareness of dengue fever and preventive measures among the Sudanese population during the war. The research focuses on understanding public knowledge, awareness, and the implementation of preventive actions in a conflict setting, aligning with various Sustainable Development Goals (SDGs).

The specific objectives include:

  • Measuring the knowledge level of the Sudanese population regarding dengue fever during the war (SDG 3, 4).
  • Evaluating awareness of preventive measures against dengue fever (SDG 3, 6).
  • Assessing the extent to which preventive measures are implemented (SDG 3, 11).
  • Investigating access to healthcare facilities during the dengue fever outbreak (SDG 3, 10).
  • Identifying the role of community participation in controlling the outbreak (SDG 3, 17).
  • Examining the correlation between knowledge levels and the implementation of preventive measures (SDG 3).

By addressing these objectives, the study aims to provide insights into public health challenges and community responses during the war, contributing to improved disease control strategies in conflict-affected areas

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

  • Inclusion Criteria: Sudanese nationals with internet access Residents in any part of Sudan age above or equal 17 years Individuals willing to participate
  • Exclusion Criteria: Non Sudanese nationals. Sudanese nationals with no internet access Residence outside Sudan age less than 17 years

Treatment and study plan

No intervention

Other

No intervention

Primary outcomes

  1. Primary Outcomes: Level of Knowledge: Percentage of the Sudanese population aware of dengue fever and its symptoms during the war

    Time frame: 1_2 months

    Using a structured, self-administered questionnaire (SAQ) based on a validated KAP survey on dengue fever.

Secondary outcomes

  1. To measure the preventive knowledge against dengue fever

    Time frame: Jan - Mar 2025

    Using a structured, self-administered questionnaire (SAQ) based on a validated KAP survey on dengue fever, in the form of (True, False, I don't know) responses.

  2. to measure the extent of implementation of preventive measures.

    Time frame: 1- 2 months

    Using a structured, self-administered questionnaire (SAQ) based on a validated KAP survey on dengue fever, in the form of Likert's scale responses.

Sponsors and collaborators

Lead sponsor

Research and Publication office

Other

Registry information

Official study title

Evaluating Public Awareness and Preventive Actions for Dengue Fever in Sudan Amidst Ongoing Crises: A Community Survey on Knowledge and Practices in Line With Related SDGs

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Oct 3, 2025
Registry last updated
Oct 3, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.